Dompe Farmaceutici S.p.A. - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Dompe Farmaceutici S.p.A. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Dompe Farmaceutici S.p.A. - Product Pipeline Review - 2015', provides an overview of the Dompe Farmaceutici S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dompe Farmaceutici S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Dompe Farmaceutici S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Dompe Farmaceutici S.p.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Dompe Farmaceutici S.p.A.'s pipeline products

Reason to Buy

- Evaluate Dompe Farmaceutici S.p.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Dompe Farmaceutici S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Dompe Farmaceutici S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Dompe Farmaceutici S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dompe Farmaceutici S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Dompe Farmaceutici S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Dompe Farmaceutici S.p.A. Snapshot 5
Dompe Farmaceutici S.p.A. Overview 5
Key Information 5
Key Facts 5
Dompe Farmaceutici S.p.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Dompe Farmaceutici S.p.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Dompe Farmaceutici S.p.A. - Pipeline Products Glance 12
Dompe Farmaceutici S.p.A. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Dompe Farmaceutici S.p.A. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Dompe Farmaceutici S.p.A. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Dompe Farmaceutici S.p.A. - Drug Profiles 16
reparixin 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ladarixin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Recombinant Human Nerve Growth Factor 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
DF-2593A 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecules to Antagonize CXCR1/2 for Bladder and Prostate Cancer 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Dompe Farmaceutici S.p.A. - Pipeline Analysis 22
Dompe Farmaceutici S.p.A. - Pipeline Products by Target 22
Dompe Farmaceutici S.p.A. - Pipeline Products by Route of Administration 23
Dompe Farmaceutici S.p.A. - Pipeline Products by Molecule Type 24
Dompe Farmaceutici S.p.A. - Pipeline Products by Mechanism of Action 25
Dompe Farmaceutici S.p.A. - Recent Pipeline Updates 26
Dompe Farmaceutici S.p.A. - Dormant Projects 28
Dompe Farmaceutici S.p.A. - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32

List of Tables

Dompe Farmaceutici S.p.A., Key Information 5
Dompe Farmaceutici S.p.A., Key Facts 5
Dompe Farmaceutici S.p.A. - Pipeline by Indication, 2015 7
Dompe Farmaceutici S.p.A. - Pipeline by Stage of Development, 2015 8
Dompe Farmaceutici S.p.A. - Monotherapy Products in Pipeline, 2015 9
Dompe Farmaceutici S.p.A. - Out-Licensed Products in Pipeline, 2015 10
Dompe Farmaceutici S.p.A. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
Dompe Farmaceutici S.p.A. - Phase III, 2015 12
Dompe Farmaceutici S.p.A. - Phase II, 2015 13
Dompe Farmaceutici S.p.A. - Phase I, 2015 14
Dompe Farmaceutici S.p.A. - Preclinical, 2015 15
Dompe Farmaceutici S.p.A. - Pipeline by Target, 2015 22
Dompe Farmaceutici S.p.A. - Pipeline by Route of Administration, 2015 23
Dompe Farmaceutici S.p.A. - Pipeline by Molecule Type, 2015 24
Dompe Farmaceutici S.p.A. - Pipeline Products by Mechanism of Action, 2015 25
Dompe Farmaceutici S.p.A. - Recent Pipeline Updates, 2015 26
Dompe Farmaceutici S.p.A. - Dormant Developmental Projects,2015 28
Dompe Farmaceutici S.p.A., Other Locations 29
Dompe Farmaceutici S.p.A., Subsidiaries 30